{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:42:53Z","timestamp":1756464173849},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.16-119","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T22:06:11Z","timestamp":1478210771000},"page":"742-746","source":"Crossref","is-referenced-by-count":7,"title":["Associations Between &lt;i&gt;TIM1&lt;\/i&gt; Polymorphisms and Dilated Cardiomyopathy in a Han Chinese Population"],"prefix":"10.1536","volume":"57","author":[{"given":"Xiaochuan","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Cardiology, West China Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Translational Medicine, West China Second University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maron BJ, Towbin JA, Thiene G, <i>et al<\/i>. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-16.","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lakdawala NK, Winterfield JR, Funke BH. Dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2013; 6: 228-37. (Review)","DOI":"10.1161\/CIRCEP.111.962050"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yoshikawa T, Baba A, Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 2009; 73: 602-7. (Review)","DOI":"10.1253\/circj.CJ-08-1151"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baba A, Yoshikawa T, Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-9.","DOI":"10.1016\/S0735-1097(02)02075-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. St\u00f6rk S, Boivin V, Horf R, <i>et al<\/i>. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006; 152: 697-704.","DOI":"10.1016\/j.ahj.2006.05.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baba A, Yoshikawa T, Fukuda Y, <i>et al<\/i>. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004; 25: 1108-15.","DOI":"10.1016\/j.ehj.2004.05.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lauer B, Schannwell M, K\u00fchl U, Strauer BE, Schultheiss HP. Anti-myosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000; 35: 11-8.","DOI":"10.1016\/S0735-1097(99)00485-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mobini R, Maschke H, Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 2004; 3: 277-84. (Review)","DOI":"10.1016\/j.autrev.2003.10.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-63.","DOI":"10.1161\/01.CIR.0000048147.15962.31"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010; 235: 172-89. (Review)","DOI":"10.1111\/j.0105-2896.2010.00903.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Su EW, Lin JY, Kane LP. TIM-1 and TIM-3 proteins in immune regulation. Cytokine 2008; 44: 9-13. (Review)","DOI":"10.1016\/j.cyto.2008.06.013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Richardson P, McKenna W, Bristow M, <i>et al<\/i>. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-2.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee CS, Chien CV, Bidwell JT, <i>et al<\/i>. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord 2014; 14: 73.","DOI":"10.1186\/1471-2261-14-73"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shamszad P, Hall M, Rossano JW, <i>et al<\/i>. Characteristics and outcomes of heart failure-related intensive care unit admissions in children with cardiomyopathy. J Card Fail 2013; 19: 672-7.","DOI":"10.1016\/j.cardfail.2013.08.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang Y, Ji H, Shen X, <i>et al<\/i>. Targeting TIM-1 on CD4 T Cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transplant 2013; 13: 56-66.","DOI":"10.1111\/j.1600-6143.2012.04316.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Umetsu SE, Lee WL, McIntire JJ, <i>et al<\/i>. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6: 447-54.","DOI":"10.1038\/ni1186"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kobayashi N, Karisola P, Pe\u00f1a-Cruz V, <i>et al<\/i>. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27: 927-40.","DOI":"10.1016\/j.immuni.2007.11.011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kim HY, Chang YJ, Chuang YT, <i>et al<\/i>. T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death. J Allergy Clin Immunol 2013; 132: 414-25.","DOI":"10.1016\/j.jaci.2013.03.025"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Griffith TS and Ferguson TA. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 2011; 35: 456-66. (Review)","DOI":"10.1016\/j.immuni.2011.08.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shirzade H, Meshkat R, Ganjalikhani-Hakemi M, <i>et al<\/i>. Association analysis of -416 G&gt;C polymorphism of T-cell immunoglobulin and mucin domain-1 gene with asthma in Iran. Int J Immunogenet 2015; 42: 265-9.","DOI":"10.1111\/iji.12209"},{"key":"21","unstructured":"21. Mete F, Ozkaya E, Aras S, Koksal V, Etlik O, Baris I. Association between gene polymorphisms in TIM, TSLP, IL18R1 and childhood asthma in Turkish population. Int J Clin Exp Med 2014; 7: 1071-7."},{"key":"22","unstructured":"22. Mou Z, Shi J, Tan Y, <i>et al<\/i>. Association between TIM-1 gene polymorphisms and allergic rhinitis in a Han Chinese population. J Investig Allergol Clin Immunol 2010; 20: 3-8."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Page NS, Jones G, Stewart GJ. Genetic association studies between the T cell immunoglobulin mucin (TIM) gene locus and childhood atopic dermatitis. Int Arch Allergy Immunol 2006; 141: 331-6.","DOI":"10.1159\/000095459"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mosaad YM, El-bassiony SR, El-Ghaweet AE, Elhindawy MM, El-Deek BS, Sultan WA. TIM-1 rs41297579 G&gt;A (-1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity. Int J Immunogenet 2015; 42: 254-64.","DOI":"10.1111\/iji.12201"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Xu JR, Yang Y, Liu XM, Sun JY, Wang YJ. Polymorphisms of the TIM-1 gene are associated with rheumatoid arthritis in the Chinese Hui minority ethnic population. Genet Mol Res 2012; 11: 61-9.","DOI":"10.4238\/2012.January.9.7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zheng K, Xu G, Lu X, Zhang J, Zhang P. Expression and polymorphisms of T cell immunoglobulin domain and mucin domain protein-1 in thymoma with or without myasthenia gravis. Oncol Lett 2014; 8: 317-22.","DOI":"10.3892\/ol.2014.2090"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kim HY, Eyheramonho MB, Pichavant M, <i>et al<\/i>. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011; 121: 1111-8.","DOI":"10.1172\/JCI44182"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wojcik G, Latanich R, Mosbruger T, <i>et al<\/i>. Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. J Infect Dis 2014; 209: 355-9.","DOI":"10.1093\/infdis\/jit444"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kuroda M, Fujikura D, Noyori O, <i>et al<\/i>. A polymorphism of the TIM-1 IgV domain: implications for the susceptibility to filovirus infection. Biochem Biophys Res Comun 2014; 455: 223-8.","DOI":"10.1016\/j.bbrc.2014.10.144"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Liu Q, Shang L, Li J, <i>et al<\/i>. A functional polymorphism in the TIM-1 gene is associated with asthma in a Chinese Han population. Int Arch Allergy Immunol 2007; 144: 197-202.","DOI":"10.1159\/000103992"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nuchnoi P, Ohashi J, Kimura R, <i>et al<\/i>. Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand. Ann Hum Genet 2008; 72: 327-36.","DOI":"10.1111\/j.1469-1809.2007.00424.x"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/6\/57_16-119\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:45:41Z","timestamp":1498358741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/6\/57_16-119\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-119","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}